https://www.pharmiweb.com/press-release/2022-10-02/new-data-reveal-molecular-drivers-of-thyroid-eye-disease-ted-may-remain-activated-in-patients-with
0
0
10/2/22 at 6:22pm
Organization
PharmiWeb.com
Author
Businesswire
55 words
0
Comments
-- Oral presentation at AAO 2022 suggests IGF-1 and its related pathways are extensively upregulated throughout all stages of TED --DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new data defining molecula…
You are the first to view
Create an account
or login to join the discussion